Lurasidone: Uses, Safety and Drug Interactions

Lurasidone: uses, safety and drug interactions

Overview: Lurasidone is an atypical antipsychotic taken by mouth. The European Latuda product information reviewed here covers schizophrenia in adults and adolescents aged 13 years and older. This summary concerns the oral tablets and does not establish that every international indication or tablet strength is interchangeable. Treatment requires an individual psychiatric assessment.

Uses and formulation: Take the prescribed tablet with a meal and swallow it whole. Taking lurasidone without food can reduce the amount absorbed. European strengths can be expressed differently from products labelled by their hydrochloride salt in another country. Do not change brands, strengths or dosing schedules on the basis of an online equivalence calculation. Avoid grapefruit juice.

Safety: Common problems include restlessness, nausea and insomnia; sleepiness, dizziness and movement symptoms can also occur. Fever with muscle rigidity or confusion, fainting, a severe rash or new suicidal thoughts need urgent medical attention. Blood sugar, weight and movement symptoms may need monitoring. Pregnancy and breastfeeding require a specific benefit–risk discussion, rather than assuming that limited information proves safety.

Drug interactions: Strong CYP3A4 inhibitors such as clarithromycin, itraconazole and ritonavir, and strong inducers such as carbamazepine, phenytoin and rifampicin, must not be combined with lurasidone under this label. Moderate inhibitors, other sedating or serotonergic medicines, and medicines affecting heart rhythm require review. Tell the prescriber about the complete medicine list; do not stop regular treatment or adjust a dose yourself.

Sources

• EMA Latuda: summary of product characteristics
• FDA clinical CYP enzyme and transporter interaction examples

This page provides an English summary of the cited sources. Source check: 30 October 2026. This date records a source check, not a clinical review by a doctor or pharmacist. Follow the current leaflet for your product and seek professional advice for personal treatment.